Neurocrine Biosciences PEG Ratio

Neurocrine Biosciences posts a PEG ratio of 58.86. That is above the Healthcare sector average of 11.77. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a PEG ratio near 11.77 is typical. Neurocrine Biosciences's 58.86 is higher that level. That is roughly 400.0% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Neurocrine Biosciences's PEG ratio of 58.86 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for 0K6R.L's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.77), and (3) consistency with growth and profitability. This page covers the first two; Neurocrine Biosciences's other metric pages and overview cover the third.

Judging Neurocrine Biosciences against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in PEG ratio easier to interpret. Start with 58.86 here, then scan peer and history charts to see if the gap is persistent.